These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 24799421)

  • 1. BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction.
    Meng S; Zhang L; Tang Y; Tu Q; Zheng L; Yu L; Murray D; Cheng J; Kim SH; Zhou X; Chen J
    J Dent Res; 2014 Jul; 93(7):657-62. PubMed ID: 24799421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micromolar sodium fluoride mediates anti-osteoclastogenesis in Porphyromonas gingivalis-induced alveolar bone loss.
    Bhawal UK; Lee HJ; Arikawa K; Shimosaka M; Suzuki M; Toyama T; Sato T; Kawamata R; Taguchi C; Hamada N; Nasu I; Arakawa H; Shibutani K
    Int J Oral Sci; 2015 Dec; 7(4):242-9. PubMed ID: 26674426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells.
    Ko SY
    Arch Oral Biol; 2012 Dec; 57(12):1623-32. PubMed ID: 22795564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monotropein Protects against Inflammatory Bone Loss and Suppresses Osteoclast Formation and Bone Resorption by Inhibiting NFATc1 via NF-κB and Akt/GSK-3β Pathway.
    Zhang Q; Hu S; He Y; Song Z; Shen Y; Zhao Z; Zhang Q; Qin L; Zhang Q
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lipopolysaccharide-induced osteoclast formation and bone resorption in vitro and in vivo by cysteine proteinase inhibitors.
    Strålberg F; Kassem A; Kasprzykowski F; Abrahamson M; Grubb A; Lindholm C; Lerner UH
    J Leukoc Biol; 2017 May; 101(5):1233-1243. PubMed ID: 28196851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norisoboldine suppresses osteoclast differentiation through preventing the accumulation of TRAF6-TAK1 complexes and activation of MAPKs/NF-κB/c-Fos/NFATc1 Pathways.
    Wei ZF; Tong B; Xia YF; Lu Q; Chou GX; Wang ZT; Dai Y
    PLoS One; 2013; 8(3):e59171. PubMed ID: 23536866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F-spondin inhibits differentiation of clastic precursors via lipoprotein receptor-related protein 8 (LRP8).
    Oka H; Kitagawa M; Takata T
    J Periodontol; 2015 Mar; 86(3):465-72. PubMed ID: 25299387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation.
    Rodrigues WF; Madeira MF; da Silva TA; Clemente-Napimoga JT; Miguel CB; Dias-da-Silva VJ; Barbosa-Neto O; Lopes AH; Napimoga MH
    Br J Pharmacol; 2012 Apr; 165(7):2140-51. PubMed ID: 21950592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
    Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M
    Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
    Gong W; Dou H; Liu X; Sun L; Hou Y
    Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory Effects of
    Kim H; Kim C; Kim DU; Chung HC; Hwang JK
    J Microbiol Biotechnol; 2018 Mar; 28(3):357-366. PubMed ID: 29212295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
    Koide N; Kondo Y; Odkhuu E; Ulziisaikhan J; Ukaji T; Yokochi T; Umezawa K
    Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory Effects of Panduratin A on Periodontitis-Induced Inflammation and Osteoclastogenesis through Inhibition of MAPK Pathways In Vitro.
    Kim H; Kim MB; Kim C; Hwang JK
    J Microbiol Biotechnol; 2018 Feb; 28(2):190-198. PubMed ID: 29061028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
    Rahman MM; Bhattacharya A; Fernandes G
    J Lipid Res; 2006 Aug; 47(8):1739-48. PubMed ID: 16702601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I-BET151 suppresses osteoclast formation and inflammatory cytokines secretion by targetting BRD4 in multiple myeloma.
    Guo NH; Zheng JF; Zi FM; Cheng J
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30455393
    [No Abstract]   [Full Text] [Related]  

  • 16. Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-κB.
    Kang MR; Jo SA; Yoon YD; Park KH; Oh SJ; Yun J; Lee CW; Nam KH; Kim Y; Han SB; Yu J; Rho J; Kang JS
    Mar Drugs; 2014 Nov; 12(11):5643-56. PubMed ID: 25421321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ampelopsis brevipedunculata extract prevents bone loss by inhibiting osteoclastogenesis in vitro and in vivo.
    Kim JY; Park SH; Oh HM; Kwak SC; Baek JM; Lee MS; Rho MC; Oh J
    Molecules; 2014 Nov; 19(11):18465-78. PubMed ID: 25397737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acteoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-κB pathway and attenuating ROS production.
    Lee SY; Lee KS; Yi SH; Kook SH; Lee JC
    PLoS One; 2013; 8(12):e80873. PubMed ID: 24324641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
    Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC
    Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.